Hasan Md Kamrul, Yaguchi Tomoko, Sugihara Takashi, Kumar Penmetcha K R, Taira Kazunari, Reddel Roger R, Kaul Sunil C, Wadhwa Renu
Research Center for Glycoscience, National Institute of Advanced Industrial Science and Technology (AIST), 1-1-1 Higashi, Tsukuba, Ibaraki 305-8566, Japan.
J Biol Chem. 2002 Oct 4;277(40):37765-70. doi: 10.1074/jbc.M204177200. Epub 2002 Aug 1.
The INK4a locus on chromosome 9p21 encodes two structurally distinct tumor suppressor proteins, p16(INK4a) and the alternative reading frame protein, ARF (p19(ARF) in mouse and p14(ARF) in human). Each of these proteins has a role in senescence of primary cells and activates pathways for cell cycle control and tumor suppression. The current prevailing model proposes that p19(ARF) activates p53 function by antagonizing its degradation by MDM2. It was, however, recently shown that stabilization of p53 by p14(ARF) occurs independent of the relocalization of MDM2 to the nucleolus. We have identified a novel collaborator of ARF, CARF. It co-localizes and interacts with ARF in the nucleolus. We demonstrate that CARF is co-regulated with ARF, cooperates with it in activating p53, and thus acts as a novel component of the ARF-p53-p21 pathway.
位于9号染色体p21区域的INK4a基因座编码两种结构不同的肿瘤抑制蛋白,即p16(INK4a)和可读框移码蛋白ARF(小鼠中为p19(ARF),人类中为p14(ARF))。这些蛋白各自在原代细胞衰老中发挥作用,并激活细胞周期调控和肿瘤抑制途径。当前流行的模型提出,p19(ARF)通过拮抗MDM2对p53的降解来激活p53功能。然而,最近有研究表明,p14(ARF)对p53的稳定作用独立于MDM2重新定位到核仁的过程。我们鉴定出了ARF的一个新的协同因子CARF。它与ARF在核仁中共定位并相互作用。我们证明,CARF与ARF共同受调控,在激活p53过程中与ARF协同作用,因此作为ARF-p53-p21途径的一个新组分发挥作用。